As of 4:00pm ET
| -0.30 / -1.17%|
The 7 analysts offering 12-month price forecasts for Medicines Co have a median target of 51.00, with a high estimate of 54.00 and a low estimate of 38.00. The median estimate represents a +101.02% increase from the last price of 25.37.
The current consensus among 6 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.